Core Viewpoint - The acquisition of global surface solutions business by Global New Materials International (06616) marks a significant step in expanding its geographic coverage and sales channels, enhancing its global presence in key markets, particularly in the automotive and cosmetics sectors [1] Group 1: Strategic Acquisition - The strategic acquisition completed on July 31, 2025, allows the company to integrate highly complementary businesses, accelerating penetration into premium global markets [1] - The integration of global operations in high-performance materials, cosmetics, and industrial applications will enrich the company's product portfolio and enhance competitiveness [1] Group 2: Supply Chain and Operational Efficiency - The transaction strengthens the company's supply chain and provides a clear cost reduction pathway to achieve synergies, benefiting customers and improving overall operational efficiency [1] - New production facilities located in Germany, Japan, and the United States will serve as regional hubs for the expanded business [1] Group 3: Research and Development - The acquisition is expected to enhance the company's technological research and development capabilities, contributing to improved environmental, social, and governance standards [1]

格隆汇7月31日丨环球新材国际(06616.HK)公告，内容有关(其中包括)收购全球业务的非常重大收购事 项。成交已于2025年7月31日落实。 此次策略性收购全球业务，使集团得以进一步扩大其主营业务的地域覆盖及销售渠道，标志着集团的全 球布局迈出重要一步。高度互补的业务整合将加快本集团对全球重点优质市场的渗透，特别是汽车及化 妆品领域。透过整合全球业务在高性能材料、化妆品及工业应用领域的专业解决方案，集团得以进一步 丰富其产品组合，提升其主营业务的竞争力。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 GLOBAL NEW MATERIAL INTERNATIONAL HOLDINGS LIMITED 環球新材國際控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：06616） 完成收購全球表面解決方案業務 本公告由環球新材國際控股有限公司（「本公司」）董事（「董事」）會（「董事會」）發佈。 董事會欣然宣佈，成交已於二零二五年七月三十一日落實。 此次策略性收購全球業務，使本集團得以進一步擴大其主營業務的地域覆蓋及銷售 渠道，標誌著本集團的全球佈局邁出重要一步。高度互補的業務整合將加快本集團 對全球重點優質市場的滲透，特別是汽車及化妝品領域。透過整合全球業務在高性 能材料、化妝品及工業應用領域的專業解決方案，本集團得以進一步豐富其產品組 合，提升其主營業務的競爭力。 – 1 – 是次交易亦有助於強化本集團的供應鏈，並提供明確的降本路徑以實現協同效應， 從而使客戶受益並全面提升本集團的營運效率。新 ...

Group 1: Market Developments - Hong Kong Stock Exchange will lower the minimum price fluctuation for stocks starting August 4, 2025, following successful market rehearsals and regulatory approvals [1] - The Hang Seng Index's ADR closed at 24,987.99 points, down 6.15 points or 0.02% [3] Group 2: Index Adjustments - The Hang Seng Index announced changes to the calculation method of the Hang Seng Hong Kong Stock Connect Innovative Drug Selection Index, effective from the index review on June 30, 2025 [2] Group 3: Company Earnings - Cathay Pacific reported a 23.3% year-on-year increase in passenger numbers, carrying approximately 2.9 million passengers in June 2025 [8] - China Longgong expects a significant increase in net profit for the first half of 2025, estimated between RMB 590 million and RMB 665 million, representing a year-on-year increase of 29% to 45% [11] - Meitu Company anticipates a 65% to 72% year-on-year growth in adjusted net profit for the first half of 2025 [10] - Hengtou Securities expects a net profit of approximately RMB 239 million for the first half of 2025, a significant increase from RMB 53.87 million in the same period last year [14] - Huiri Group forecasts a consolidated profit of approximately HKD 250 million for the first half of 2025, up from HKD 37 million in the previous year [15] - Harbin Electric anticipates a net profit of approximately RMB 1.02 billion for the first half of 2025, a substantial increase from RMB 523 million in the same period last year [21] Group 4: Strategic Initiatives - Multiple departments released implementation details for cross-border asset management pilot business in Hainan Free Trade Port, allowing foreign investors to invest in various financial products [6] - Dongyangguang Jiangsu Pharmaceutical and Dongyangguang Pharmaceutical's merger agreement was approved by shareholders, with the new entity expected to be listed on August 7, 2025 [13] - Global New Materials International's acquisition of Merck's surface solutions business was approved by a special shareholder meeting, with a transaction value of EUR 665 million [17] Group 5: Industry Trends - GGII reported that China's power battery installation capacity reached approximately 288.1 GWh in the first half of 2025, a year-on-year increase of 44% [5] - The key product DB-1310 from InnoCare Pharma has received fast track designation from the FDA for treating advanced non-small cell lung cancer [20]

Core Viewpoint - The acquisition of Merck Surface Solutions by Global New Materials International is a strategic move aimed at accelerating the company's expansion and reshaping the surface performance materials industry landscape [2][7]. Group 1: Acquisition Details - The acquisition plan was approved unanimously at the shareholders' meeting, with Global New Materials International set to acquire 100% of Merck Surface Solutions for €665 million (approximately ¥5.187 billion), valuing the transaction at 11.08 times the 2023 EBIT [2][6]. - Merck Surface Solutions reported approximately €405 million in revenue and €60 million in EBIT for the fiscal year 2023, holding a significant position in the high-quality pearlescent pigment market, particularly in the automotive and cosmetics sectors [2][3]. Group 2: Strategic Expansion - Global New Materials International has been actively expanding, having previously acquired a 42.45% stake in South Korea's largest pearlescent pigment manufacturer, CQV, in 2023, with plans to increase this stake to 45.11% by 2025 [3]. - The company is also developing a new project in Tonglu, Hangzhou, with an annual production capacity of 100,000 tons of synthetic mica, further enhancing its market presence [3]. Group 3: Synergy and Market Position - The acquisition is expected to create significant synergies beyond mere capacity expansion, including enhanced sales channels, product offerings, and supply chain efficiencies [4][5]. - Merck Surface Solutions' established customer base in high-end markets, including luxury automotive and leading cosmetics brands, will provide Global New Materials International with valuable access to international markets [4][5]. Group 4: Future Integration Plans - The integration of Merck Surface Solutions is anticipated to be completed by July 2025, with a focus on deepening collaboration across various operational dimensions, including production, supply chain, R&D, and human resources [6]. - The strategic acquisition aligns with the trend of consolidation in the pearlescent pigment industry, positioning Chinese enterprises to become global leaders in this sector [7].

Summary of Key Points Core Viewpoint - As of July 14, a total of 138 stocks reached their 52-week highs, indicating a strong performance in the market, with notable leaders including Green Heart Group Holdings, OK Blockchain, and Pearl River Steel Pipe [1]. Group 1: Top Performers - Green Heart Group Holdings (02999) achieved a closing price of 0.013 with a peak of 0.017, marking a 70.00% increase [1]. - OK Blockchain (01499) closed at 0.680, reaching a high of 0.690, reflecting a 48.39% rise [1]. - Pearl River Steel Pipe (01938) had a closing price of 0.335 and a peak of 0.340, resulting in a 33.33% increase [1]. Group 2: Other Notable Stocks - Weishi Jiajie (00856) saw a 32.01% increase, closing at 8.870 with a high of 11.300 [1]. - Cloud Intelligence (09678) reached a high of 520.000, closing at 510.000, which is a 20.99% increase [1]. - China Chengtong Development Group (00217) closed at 0.165 with a peak of 0.166, marking a 14.48% rise [1]. Group 3: Additional Stocks with Significant Increases - Sihuan Pharmaceutical (00460) closed at 1.380, reaching a high of 1.430, which is a 14.40% increase [1]. - Taited Pharmaceutical (03880) had a closing price of 36.950 and a peak of 37.400, reflecting a 13.85% rise [1]. - Beihai Kangcheng-B (01228) closed at 0.850 with a high of 0.960, resulting in a 12.94% increase [1].

Core Viewpoint - As of July 4, 2023, Global New Materials International (06616.HK) shares closed at 5.150 HKD, marking a 0.39% increase from the previous trading day, with an intraday high of 5.320 HKD, reaching a nearly one-year high [1] Company Overview - Global New Materials International Holdings Limited is a national high-tech enterprise focused on the R&D, production, and sales of pearlescent materials and artificial synthetic mica, ranked among the top in its industry globally [2] - The company has received numerous accolades, including "National Intellectual Property Advantage Enterprise," "National Green Factory," and "China's 500 Most Valuable Brands," among others [2] - It is a key participant in the Ministry of Industry and Information Technology's industrial foundation engineering project for artificial synthetic mica, possessing leading core technologies and multiple patents in synthetic mica and pearlescent materials [2] Product Range and Applications - The company offers a comprehensive range of over 2,000 varieties of pearlescent materials and synthetic mica products, covering high, medium, and low-end categories, including industrial-grade, weather-resistant, and cosmetic-grade products [2] - Its products are widely used across various sectors, including coatings, automotive paints, cosmetics, aerospace, military, ship anti-corrosion, plastics, inks, ceramics, leather, construction materials, 3D printing, anti-counterfeiting, and seed coating [2] - The company has established a global marketing network, exporting products to over 100 countries and regions [2]

Group 1: Market Overview - The Hang Seng Index fell by 0.96%, down 232 points, closing at 23,989 points, while the Hang Seng Tech Index decreased by 1.20% [1] - The Hong Kong stock market saw a trading volume of HKD 130.6 billion in the morning session [1] Group 2: Pharmaceutical Sector - The National Healthcare Security Administration and the National Health Commission released measures to support the high-quality development of innovative drugs, indicating that innovative drugs remain a key investment theme [1] - The Hang Seng Biotechnology Index surged by 2.79% [1] - Ascentage Pharma-B (06855) rose by 8%, Kelun-Biotech (06990) increased by 7%, and Zai Lab (09688) gained 5.21% [1] - Kangfang Biotech (09926) saw a rise of over 11% as its first dual-antibody ADC drug AK146D1 entered clinical enrollment [2] - Innovent Biologics (01801) increased by over 6% following the approval of its drug Ma Shidu Peptide for commercialization [3] - CStone Pharmaceuticals-B (02616) rose by over 11% after disclosing two dual-specific antibody drug targets, CS2013 and CS2015 [4] - Sihuan Pharmaceutical (02096) gained 4.43% after its new generation anti-VEGF monoclonal antibody "Suvetizumab" was approved for market [5] Group 3: Other Sectors - Gaming stocks continued to rise, with Macau's June gaming revenue exceeding expectations, and Citigroup predicts growth momentum will continue in the second half of the year [5] - MGM China (02282) increased by 2.6%, and Melco International Development (00200) rose by 1.75% [5] - Wheelock Properties (01997) gained 7.32% as Hong Kong's retail sales value rebounded in May, leading Morgan Stanley to upgrade the company's rating [5] - Global New Material International (06616) rose by over 5% as the acquisition of Merck's surface solutions business is nearing completion [6] - Giant Star Legend (06683) increased by over 3% after its subsidiary invested USD 8 million in the Starlight New Economy Industry Fund [7] - Kingsoft (03888) fell nearly 7% as its new game "Unrestricted Machine" entered public testing, with market attention on its performance [8]

Company Overview - Global New Materials International Holdings Limited is a national high-tech enterprise focused on the R&D, production, and sales of pearlescent materials and artificial synthetic mica, with stock code 06616.HK [2] - The company ranks among the top in its industry globally and has received various accolades, including "National Intellectual Property Advantage Enterprise" and "National Green Factory" [2] - It is a key participant in the Ministry of Industry and Information Technology's industrial foundation engineering project for synthetic mica, holding several core patents and a comprehensive product range [2] Financial Performance - As of December 31, 2024, the company achieved total operating revenue of 1.649 billion yuan, representing a year-on-year growth of 54.95% [1] - The net profit attributable to the parent company was 242 million yuan, with a year-on-year increase of 33.37% [1] - The gross profit margin stood at 52.99%, and the debt-to-asset ratio was 38.29% [1] Market Position and Valuation - The company's price-to-earnings (P/E) ratio is 20.04, ranking 29th in its industry, while the average P/E ratio for the raw materials sector is 15.29 [1] - Other companies in the same sector have significantly lower P/E ratios, such as Dazheng Biochemical Technology at 0.85 and Zhongmu International at 1.57 [1] Product Applications and Market Reach - The company's products are widely used across various sectors, including coatings, automotive paints, cosmetics, aerospace, military, ship anti-corrosion, plastics, inks, ceramics, leather, construction materials, 3D printing, anti-counterfeiting, and seed coating [2] - Global New Materials has established a marketing network covering major countries worldwide, exporting products to over 100 countries and regions [2]

Group 1 - This week, 10 listed companies announced share buybacks and capital increase through special loans, including Weichai Power, which received a commitment letter for a buyback loan not exceeding 900 million yuan [1][2] - Weichai Power plans to repurchase shares amounting to 500 million to 1 billion yuan to cancel and reduce its registered capital [1][2] Group 2 - Jianyou Co. announced a buyback with loan support not exceeding 36 million yuan on May 22 [2] - Gongniu Group received a commitment letter for a buyback loan not exceeding 360 million yuan on May 22 [2] - Fenda Technology obtained a commitment letter for a buyback loan not exceeding 90 million yuan on May 21 [2] - Xingshuai Er received a commitment letter for a buyback loan not exceeding 34.55 million yuan on May 20 [2] - Hexing Packaging plans to repurchase shares between 50 million to 100 million yuan with a loan not exceeding 90 million yuan [2] - Anhui Construction's controlling shareholder received loan support not exceeding 180 million yuan for capital increase on May 23 [2] - Hubei Yihua's controlling shareholder obtained a commitment letter for a capital increase loan not exceeding 360 million yuan on May 22 [2] - Tunnel Co.'s controlling shareholder received loan support not exceeding 450 million yuan for capital increase on May 22 [2] - Shanghai Laishi's controlling shareholder plans to increase shares between 250 million to 500 million yuan with a loan not exceeding 450 million yuan [2]